Dr. Munster on Vorinostat Plus Tamoxifen for Breast Cancer
October 23rd 2012Pamela Munster, MD, from UCSF Helen Diller Family Comprehensive Cancer Center, discusses results from a phase II study that examined vorinostat in combination with tamoxifen for endocrine therapy-resistant breast cancer.
Read More